BETHANY BALL: Open Payments
NPI 1972223915 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 15 payments from 6 companies in 2025. Trend: 2023 $833 · 2024 $698 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $135 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| ABBVIE INC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Corium, LLC | 1 | $8 |
Products named: FANAPT, Auvelity, SPRAVATO, VRAYLAR, CAPLYTA, Azstarys.
Industry payments across MS — which companies pay providers there.
